Research to develop the basis for the pharmaceuticals of the future – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

Health > News > News 2016 > Christian Adam Olsen

14 December 2016

Research to develop the basis for the pharmaceuticals of the future

ERC Consolidator Grant

Professor Christian Adam Olsen from the Center for Biopharmaceuticals at the Department of Drug Design and Pharmacology, has been awarded the prestigious ERC Consolidator Grant.

Christian Adam Olsen’s pulse increased more than slightly when he was battling with the application system, attempting to open the electronic document containing the decision as to whether he and his team of researchers had been awarded the coveted ERC Consolidator Grant. But there was no call to be nervous. Deep into the document, the message was particularly positive. Christian Adam Olsen had been awarded the coveted 5-year grant that is presented to researchers who have displayed extraordinary talent and excellent results.

“The grant is a great mark of recognition for the research we’re doing, and I’m both proud and delighted to receive it. A pat on the back of this calibre naturally boosts motivation in our everyday work. Moreover, the grant is a key consolidating factor for our research, helping to ensure a level of continuity that gives us the peace of mind to immerse ourselves in the project,” he says.

New technologies hold the key to the future
Christian Adam Olsen has always been interested in pharmaceuticals, with the emphasis on the chemical foundations. His field of research centres on the application of organic chemistry methods to investigate enzyme kinetics and processes in living cells. One key aspect of his research comprises developing technologies and discovering new biological mechanisms and methods for inhibiting illness-relevant mechanisms. And it is precisely this research the new grant will be supporting.

“In our research, we strive to use our chemical knowledge to develop methods that allow us to learn more about biological mechanisms relevant to illness. In the long term, we hope to be able to lay the foundations for the development of pharmaceuticals in a variety of areas of illness. One of the things we want to look at in the context of this project is possible links between cancer and metabolism We are keen to investigate this down to molecular level, and the new grant puts us in a position to do so,” concludes Christian Adam Olsen.

Christian Adam Olsen has an MSc from the Technical University of Denmark (DTU) and a PhD from the Faculty of Pharmaceutical Sciences. He has also held a postdoc position at The Scripps Research Institute in La Jolla, California, USA. It was here that Christian Adam Olsen developed his interest in his field of research, laying the foundations on which he continues to build at SUND.

Contact:
Christian Adam Olsen, email: cao@sund.ku.dk, mobile: +45 2228 2006